GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » FCF Margin %

IQMDU (Intelligent Medicine Acquisition) FCF Margin % : 0.00% (As of Dec. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Intelligent Medicine Acquisition FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Intelligent Medicine Acquisition's Free Cash Flow for the three months ended in Dec. 2022 was $-0.45 Mil. Intelligent Medicine Acquisition's Revenue for the three months ended in Dec. 2022 was $0.00 Mil. Therefore, Intelligent Medicine Acquisition's FCF Margin % for the quarter that ended in Dec. 2022 was 0.00%.

As of today, Intelligent Medicine Acquisition's current FCF Yield % is -1.05%.

The historical rank and industry rank for Intelligent Medicine Acquisition's FCF Margin % or its related term are showing as below:


IQMDU's FCF Margin % is not ranked *
in the Diversified Financial Services industry.
Industry Median: -0.935
* Ranked among companies with meaningful FCF Margin % only.


Intelligent Medicine Acquisition FCF Margin % Historical Data

The historical data trend for Intelligent Medicine Acquisition's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Medicine Acquisition FCF Margin % Chart

Intelligent Medicine Acquisition Annual Data
Trend Dec21 Dec22
FCF Margin %
- -

Intelligent Medicine Acquisition Quarterly Data
Feb21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22
FCF Margin % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Intelligent Medicine Acquisition's FCF Margin %

For the Shell Companies subindustry, Intelligent Medicine Acquisition's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intelligent Medicine Acquisition's FCF Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Intelligent Medicine Acquisition's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Intelligent Medicine Acquisition's FCF Margin % falls into.


;
;

Intelligent Medicine Acquisition FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Intelligent Medicine Acquisition's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-0.867/0
= %

Intelligent Medicine Acquisition's FCF Margin for the quarter that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=-0.452/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intelligent Medicine Acquisition FCF Margin % Related Terms

Thank you for viewing the detailed overview of Intelligent Medicine Acquisition's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelligent Medicine Acquisition Business Description

Traded in Other Exchanges
N/A
Address
9001 Burdette Road, Bethesda, MD, USA, 20817
Intelligent Medicine Acquisition Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Executives
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Joseph L Schocken director 2800 UNION SQUARE, 600 UNIVERSITY STREET, SEATTLE WA 98101
Kavita Patel director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jack Hidary director 3 PARK AVENUE, NEW YORK NY 10016
Gregory C Simon director, officer: CEO and CFO 9001 BURDETTE RD., BETHESDA MD 20817
Patience Marime-ball director 9001 BURDETTE RD., BETHESDA MD 20817
Intelligent Medicine Sponsor Llc 10 percent owner 9001 BURDETTE ROAD, BETHESDA MD 20817